Feature Vasomune finds nice fit in co-development pact for vascular leakage with AnGes Closely-held Vasomune Therapeutics found the right partner last month in AnGes (TYO:4563) to co-develop its Vasculotide drug candidate for the treatment of diseases associated with blood vessel leakage and pulmonary... August 28, 2018